Procter & Gamble/$PG
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Procter & Gamble
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of more than $87 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside the US represent just over half of the firm's consolidated total.
- Ticker
- $PG
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 104,000
- Headquarters
- Cincinnati, United States
- Website
- www.pginvestor.com
Procter & Gamble Metrics
BasicAdvanced
$379B
24.65
$6.64
0.38
$4.29
2.66%
Price and volume
Market cap
$379B
Beta
0.38
52-week high
$167.25
52-week low
$137.62
Average daily volume
9.2M
Dividend rate
$4.29
Financial strength
Current ratio
0.722
Quick ratio
0.489
Long term debt to equity
0.396
Total debt to equity
0.703
Dividend payout ratio (TTM)
64.18%
Interest coverage (TTM)
24.23%
Profitability
EBITDA (TTM)
25,088
Gross margin (TTM)
50.59%
Net profit margin (TTM)
18.23%
Operating margin (TTM)
24.57%
Effective tax rate (TTM)
20.85%
Revenue per employee (TTM)
$850,000
Management effectiveness
Return on assets (TTM)
10.36%
Return on equity (TTM)
29.61%
Valuation
Price to earnings (TTM)
24.649
Price to revenue (TTM)
4.317
Price to book
6.85
Price to tangible book (TTM)
-46.2
Price to free cash flow (TTM)
24.746
Free cash flow yield (TTM)
4.04%
Free cash flow per share (TTM)
6.61
Dividend yield (TTM)
2.62%
Forward dividend yield
2.66%
Growth
Revenue change (TTM)
3.52%
Earnings per share change (TTM)
-3.14%
3-year revenue growth (CAGR)
1.83%
10-year revenue growth (CAGR)
3.02%
3-year earnings per share growth (CAGR)
2.56%
10-year earnings per share growth (CAGR)
5.88%
3-year dividend per share growth (CAGR)
4.98%
10-year dividend per share growth (CAGR)
4.88%
What the Analysts think about Procter & Gamble
Analyst ratings (Buy, Hold, Sell) for Procter & Gamble stock.
Analyst projections of the future price of Procter & Gamble stock.
Bulls say / Bears say
P&G’s first quarter delivered a stronger sales mix: organic sales rose 4%, volumes increased 2.4% and adjusted earnings beat expectations. The result suggests growth is coming from selling more products, not just raising prices. (CNBC)
Recent product launches show that P&G can still win consumers in mature categories: its China baby-care products posted double-digit organic sales growth for six consecutive quarters, while an upgraded Tide liquid detergent returned to high-single-digit retail sales growth. These examples give the innovation pipeline a credible route to support future growth. (Procter & Gamble)
P&G’s cash returns add to the appeal for income-focused investors: it raised its dividend for a 70th consecutive year and returned more than $15 billion to shareholders in fiscal 2026. That record reflects substantial cash generation even in a difficult year. (Procter & Gamble)
Higher input and freight costs threaten earnings: P&G raised its estimate of the fiscal 2027 profit hit to about $1.4 billion, while core operating margin fell 80 basis points in the latest quarter. Productivity savings have not fully offset that pressure. (Investing.com)
Underlying growth was weak in fiscal 2026: organic sales rose just 1%, volumes were flat and core earnings per share increased only 1%. Management’s 1%–3% organic growth outlook for fiscal 2027 points to a modest recovery rather than a rapid acceleration. (Procter & Gamble)
The recovery is uneven across P&G’s portfolio: in the latest quarter, grooming volume fell 0.4% and healthcare volume dropped 2.9%. Value-conscious shoppers may continue to limit demand in these categories even as other businesses grow. (CNBC)
Data summarised monthly by Lightyear AI. Last updated on 22 Oct 2026.
Procter & Gamble Financial Performance
Revenues and expenses
Procter & Gamble Earnings Performance
Company profitability
Upcoming events
Procter & Gamble News
AllArticlesVideos
Procter & Gamble's Turnaround Gains Steam, but Analyst Warns Rising Oil Costs Could Threaten Recovery
Benzinga2 weeks ago
Procter & Gamble Q1 Earnings Call Highlights
MarketBeat2 weeks ago
QUICK SPARK: Procter & Gamble Stock Eyes Best Day Since 2020 – The Rally Is Hiding Something Bigger
Benzinga2 weeks ago
Funds containing Procter & Gamble
AllUSDEURGBP
Fund name | Fund size | $PG weighting |
|---|---|---|
iShares S&P 500 Consumer Staples Sector€2B7D | $533M | 11.48% |
iShares S&P 500 Consumer Staples Sector£ICSU | $533M | 11.48% |
SPDR MSCI World Consumer Staples$WCOS | $157M | 7.81% |
Xtrackers MSCI World Consumer Staples£XWCS | $926M | 7.76% |
Xtrackers MSCI World Consumer Staples$XDWS | $926M | 7.76% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.